U.S. FDA issues warning letter to Natco over facility near Hyderabad

Regulator’s action unlikely to impact supplies, existing revenues, but may delay pending product approvals from site, says drugmaker

​Regulator’s action unlikely to impact supplies, existing revenues, but may delay pending product approvals from site, says drugmaker